Busca avançada
Ano de início
Entree


Kynurenine is correlated with IL-1 beta in plasma of schizophrenia patients

Texto completo
Autor(es):
Joaquim, Helena P. G. ; Costa, Alana C. ; Gattaz, Wagner F. ; Talib, Leda Leme
Número total de Autores: 4
Tipo de documento: Artigo Científico
Fonte: JOURNAL OF NEURAL TRANSMISSION; v. 125, n. 5, p. 5-pg., 2018-05-01.
Resumo

The etiology of schizophrenia is still unclear. It is well-known that pro-inflammatory cytokines are higher in schizophrenia patients since the first episode psychosis comparing to healthy controls. Inflammatory downstream cascades influence different cellular pathways, like the displacement of the tryptophan (TRP) metabolism to the production of kynurenine (KYN) instead of serotonin, which results in the generation of several neuro and immunoactive metabolites. The aim of this study was to determine TRP, KYN and IL-1 beta plasma levels in first-onset schizophrenia (n = 28) and healthy controls (n = 30). The plasmatic levels of TRP and KYN were decreased in schizophrenic patients (p = 0.004 and p = 0.002, respectively), but there was no difference in the ratio of KYN/TRP (p = 0.554) or either in IL-1 beta (p = 0.101). Positive correlation was observed between KYN and IL-1 beta only in the schizophrenia group (r = 0.461, p = 0.021). And, there was also positive correlation between KYN and Positive and Negative Symptoms Scale (PANSS) (r = 0.395, p = 0.037). There is no correlation between the other analytes and other parameters of PANSS. Although our results of KYN have been different than expected and there was no difference in the KYN/TRP ratio, we observed a positive correlation between IL-1 beta and KYN, corroborating findings that pro-inflammatory agents hold up the KYN pathway. (AU)

Processo FAPESP: 13/10350-9 - Proteômica da esquizofrenia: busca por biomarcadores em plaquetas
Beneficiário:Helena Passarelli Giroud Joaquim Nadal
Modalidade de apoio: Bolsas no Brasil - Doutorado
Processo FAPESP: 14/50873-3 - INCT 2014: Instituto Nacional de Biomarcadores em Neuropsiquiatria (INBioN)
Beneficiário:Wagner Farid Gattaz
Modalidade de apoio: Auxílio à Pesquisa - Temático
Processo FAPESP: 14/20913-3 - Determinação de fosfolípides plasmáticos nas doenças neuropsiquiátricas
Beneficiário:Alana Caroline Costa
Modalidade de apoio: Bolsas no Brasil - Mestrado